[
    [
        {
            "time": "",
            "original_text": "刘格菘最新持仓曝光：Q1增持康泰生物，新进龙蟒佰利、恒力石化为其前十大重仓股",
            "features": {
                "keywords": [
                    "刘格菘",
                    "康泰生物",
                    "龙蟒佰利",
                    "恒力石化",
                    "重仓股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "化工"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "刘格菘最新持仓曝光：Q1增持康泰生物，新进龙蟒佰利、恒力石化为其前十大重仓股",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "山西证券：医药行业基本面良好，刚需带来确定性成长",
            "features": {
                "keywords": [
                    "山西证券",
                    "医药行业",
                    "基本面",
                    "刚需",
                    "确定性成长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "山西证券：医药行业基本面良好，刚需带来确定性成长",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "山西证券 - 医药行业周报：第五批国采或将启动，持续关注一季报业绩发布【行业研究】",
            "features": {
                "keywords": [
                    "山西证券",
                    "医药行业",
                    "第五批国采",
                    "一季报",
                    "业绩发布"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "山西证券 - 医药行业周报：第五批国采或将启动，持续关注一季报业绩发布【行业研究】",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]